Imunofan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2016
012319952016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
In the model system mice–A. tetraptera, cancelation of the nematode activity of Nilverm, in case of combined application with… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
Experiments on noninbred rats showed that the chronic intoxication with organophosphorus compounds sarin and methylparathion (30… (More)
Is this relevant?
2009
2009
AIM To potentiate the effect of basic therapy and to correct of immune dysfunction in type 2 diabetes mellitus (T2DM) patients… (More)
Is this relevant?
2009
2009
It was discovered that during the first several months military service men have suppression of several indexes of immunity and a… (More)
Is this relevant?
2007
2007
AIM To specify immunological and pathogenetic aspects of imunophan use in aged patients with duodenal ulcer (DU). MATERIAL AND… (More)
Is this relevant?
2006
2006
Hydrophilic hexapeptide Imunofan produces a modulatory effect on multiple drug resistance transport proteins depending on their… (More)
  • figure 1
  • table 1
Is this relevant?
2003
2003
Different nociceptive reactions and individual resistance were studied in rats in the initial state and in conditions of… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2001
2001
Immunofan and tactivin, employed as a means of immunological correction in the complex treatment of adenocarcinoma, decrease the… (More)
Is this relevant?
Review
1999
Review
1999
The paper reviews the development, mode of action and field of application of synthetic regulatory peptides in the pathogenetic… (More)
Is this relevant?
1996
1996
Peptide immunocorrector Imunofan was used as adjuvant to conventional treatment. A single intramuscular injection was given daily… (More)
Is this relevant?